» Articles » PMID: 30186756

Combined Pulmonary Fibrosis and Emphysema with Myeloperoxidase-antineutrophil Cytoplasmic Antibody Positivity That Resolved Upon Smoking Cessation

Overview
Date 2018 Sep 7
PMID 30186756
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Myeloperoxidase antineutrophil cytoplasmic autoantibody (MPO-ANCA) is well-known as a serological marker for small-vessel vasculitis. However, when a smoker with interstitial lung disease (ILD) exhibits serum ANCA positivity without systemic vasculitis, diagnosis is a matter of debate; the relationship between smoking and ANCA is unknown. We report a case of combined pulmonary fibrosis and emphysema (CPFE) with elevated MPO-ANCA. Surgical lung biopsy showed emphysema and fibrotic interstitial pneumonia without vasculitis. The MPO-ANCA level decreased after smoking cessation, and no vasculitis or progression was observed during 3 years of follow-up. This suggested that smoking cessation was related to normalization of MPO-ANCA and corresponding disease activity.

Citing Articles

Combined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally.

Gredic M, Karnati S, Ruppert C, Guenther A, Avdeev S, Kosanovic D Cells. 2023; 12(9).

PMID: 37174678 PMC: 10177208. DOI: 10.3390/cells12091278.


Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement.

Cottin V, Selman M, Inoue Y, Wong A, Corte T, Flaherty K Am J Respir Crit Care Med. 2022; 206(4):e7-e41.

PMID: 35969190 PMC: 7615200. DOI: 10.1164/rccm.202206-1041ST.

References
1.
Margaritopoulos G, Harari S, Caminati A, Antoniou K . Smoking-related idiopathic interstitial pneumonia: A review. Respirology. 2015; 21(1):57-64. DOI: 10.1111/resp.12576. View

2.
Jankowich M, Rounds S . Combined pulmonary fibrosis and emphysema syndrome: a review. Chest. 2012; 141(1):222-231. PMC: 3251269. DOI: 10.1378/chest.11-1062. View

3.
Homma S, Matsushita H, Nakata K . Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respirology. 2004; 9(2):190-6. DOI: 10.1111/j.1440-1843.2004.00581.x. View

4.
Gaudin P, Askin F, Falk R, Jennette J . The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol. 1995; 104(1):7-16. DOI: 10.1093/ajcp/104.1.7. View

5.
Bosch X, Guilabert A, Font J . Antineutrophil cytoplasmic antibodies. Lancet. 2006; 368(9533):404-18. DOI: 10.1016/S0140-6736(06)69114-9. View